TB-500 is a synthetic peptide containing the active sequence of thymosin beta-4, a major G-actin sequestering protein found in human and animal cells. Research indicates that TB-500 promotes cellular migration, supports vascular endothelial growth, and significantly aids in wound healing and muscle recovery models.
“The active domain of Thymosin Beta-4, known as TB-500, facilitates rapid cellular migration and actin cytoskeleton remodeling in tissue assay models.”
Advanced biochemistry data and preclinical evaluations are accessible at the PubChem Thymosin Beta-4 Database or via PubMed indexing at the PubMed TB-500 Registry for molecular biology research. Preclinical models highlight its role in dermal tissue healing.
Key Areas of Investigation:
- Actin Polymerization Regulation: Researching G-actin binding and cytoskeleton remodeling.
- Vascular Angiogenesis: Investigating endothelial cell differentiation and tube formation.
- Soft Tissue Recovery: Studies on collagen deposition and inflammatory modulation.
This material is supplied exclusively as a lyophilized solid for laboratory research and analytical evaluation, and is strictly not for human or therapeutic use.




Reviews
There are no reviews yet.